The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
Open accessAbstract
BACKGROUND AND AIMS: Post-dysenteric irritable bowel syndrome (PD-IBS) develops in up to 25% of patients following Campylobacter enteritis. Our aim was to define the pathological basis of this subgroup of IBS. METHODS: Twenty one patients (group 1) underwent serial rectal biopsy and gut permeability testing following acute Campylobacter enteritis as did 10 PD-IBS patients (group 2) and 12 asymptomatic controls. RESULTS: In group 1, enteroendocrine cell (EC) numbers were markedly increased initially and at six and 12 weeks (p<0.001) compared with controls. Gut permeability, as assessed by the lactulose/mannitol ratio, was significantly elevated, initially and at 12 weeks (p<0.005). CD3, CD4, and CD8 lymphocyte counts in the lamina propria and intraepithelial lymphocytes (IEL) were significantly increased initially compared with controls. At visit 1, EC numbers were positively correlated with CD3 counts ( r =0.6, p=0.01). At one year, seven subjects (five with persistent loose stools) had rectal biopsies which showed significantly elevated EC, CD3, and IEL counts. In group 2, EC and IEL counts were significantly increased compared with controls (p<0.001), as was gut permeability (p<0.01). CONCLUSION: Increased EC, T lymphocytes, and gut permeability are acute changes following Campylobacter enteritis which can persist for more than a year and may contribute to PD-IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, increased concentrations of CD3+ T cells in the colon and rectum and in the myenteric plexus of the small intestine were increased in these patients compared with normal controls (36, 46, 57, 58, 89, 94, 133, 168, 174).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [168]
In the citing paper
“However, some studies failed to demonstrate increased activated mast cells in IBS patients (35, 36, 57, 58, 168) and there are no consistent differences in the tissue concentrations of activated mast cells in patients with different IBS subtypes (36, 189).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [168]
In the citing paper
“The importance of the interaction between the intestinal microbiota and immune system in IBS patients is demonstrated by a few studies in patients with PI-IBS, indicating activation of the GI immune system following the acute GI infection (57, 58, 75, 89, 94, 124, 168, 170, 187)”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [168]
In the citing paper
“Similarly, mesalamine 3.2 g/day for 12 wk (168) and prednisolone 30 mg/day for 3 wk (52) were not effective in improving the GI symptoms in patients with PI-IBS.”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [168]
In the citing paper
“First, there is increasing evidence of an activation of the intestinal immune system in IBS leading in a micro-inflammation, with studies demonstrating increased concentrations of mucosal intraepithelial lymphocytes [65,66] , mast cells [6669] and 5hydroxytryptaminesecreting enterochromaffin cells [65] .”
From Gut microbiota role in irritable bowel syndrome: New therapeutic strategies (2016) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O’Garra, A., Bigler, M., Rouleau, M., Antonenko, S. V., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Human distribution and release of a putative new gut hormone, peptide YY
Adrian, T. E., Ferri, G., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., & Bloom, S. R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90211-2 · Cited by 1,064
The role of psychological and biological factors in postinfective gut dysfunction
Gwee, K.-A., Leong, Y.-L., Graham, C., McKendrick, M. W., Collins, S. M., Walters, S. J., Underwood, J. E., & Read, N. W. (1999) · Gut · doi:10.1136/gut.44.3.400 · Cited by 764
Neal, K. R., Hebden, J., & Spiller, R. (1997) · BMJ · doi:10.1136/bmj.314.7083.779 · Cited by 586
Self-citationChaudhary, N. A., & Truelove, S. C. (1962) · QJM · doi:10.1093/oxfordjournals.qjmed.a066971 · Cited by 498
Lazenby, A. J., Yardley, J. H., Giardiello, F. M., Jessurun, J., & Bayless, T. M. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90198-6 · Cited by 492
Psychometric scores and persistence of irritable bowel after infectious diarrhoea
Gwee, K., Read, N. W., Graham, J. C., McKendrick, M. W., Collins, S. M., Marshall, J. S., & Walters, S. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90341-4 · Cited by 466
Psychometric scores and persistence of irritable bowel after infectious diarrhoea
Ka, G., Graham, J. C., McKendrick, M. W., Collins, S. M., Marshall, J. S., Walters, S., & Read, N. W. (1996) · African journal of medical practice · Cited by 429
Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study
Rodríguez, L. A. G., & Ruigómez, A. (1999) · British medical journal · doi:10.1136/bmj.318.7183.565 · Cited by 409
Flagged first, then by citations
Research works printed but not linked: 5
- Jenkins, 1998, Elevated cytokines, cytotoxic product and NK cells and pathogenesis of persistent acute-onset diarrhoea., Gut, 41, A38
- Drossman, 1990, Identification of subgroups of functional gastrointestinal disorders., Gastroenterol Int, 3, 159
- Cobden, 1980, Intestinal permeability and screening tests for coeliac disease., Gut, 21, 512, 10.1136/gut.21.6.512 · DOI
- Pearson, 1982, Intestinal permeability in children with Crohn's disease and coeliac disease., BMJ, 285, 20, 10.1136/bmj.285.6334.20 · DOI
- Chen, 1998, Transforming growth factor-β in mucossal immunity and tolerance., Mucosal Immunol Update, 6, 4
Cited by
Sorted by citations
Items 101–117 of 117
Quigley, E. M. M. (2007) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.07.012 · Cited by 67
Is irritable bowel syndrome an inflammatory disorder?
De Giorgio, R., & Barbara, G. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0073-0 · Cited by 64
Martin‐Viñas, J. J., & Quigley, E. M. M. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12379 · Cited by 57
On the fiftieth anniversary Postinfectious irritable bowel syndrome: mechanisms related to pathogens
Grover, M., Camilleri, M., Smith, K., Linden, D. R., & Farrugia, G. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12304 · Cited by 48
Peters, S. A., Edogawa, S., Sundt, W. J., Dyer, R. B., Dalenberg, D. A., Mazzone, A., Singh, R. J., Moses, N., Smyrk, T. C., Weber, C., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.48 · Cited by 48
Camilleri, M., Carlson, P., McKinzie, S., Zucchelli, M., D’Amato, M., Busciglio, I., Burton, D., & Zinsmeister, A. R. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01749.x · Cited by 47
Behavioral and Complementary Approaches for the Treatment of Irritable Bowel Syndrome
Wald, A., & Rakel, D. (2008) · Nutrition in Clinical Practice · doi:10.1177/0884533608318677 · Cited by 46
Tuteja, A. K., Fang, J. C., Al-Suqi, M., Stoddard, G. J., & Hale, D. C. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.694903 · Cited by 41
Zhao, J., Wang, J., Dong, L., Shi, H., Wang, Z., Ding, H., Shi, H., & Lu, X. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.12.032 · Cited by 35
Hod, K., Dickman, R., Sperber, A., Melamed, S., Dekel, R., Ron, Y., Halpern, Z., Berliner, S., & Maharshak, N. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01788.x · Cited by 36
A pilot study of colonic B cell pattern in irritable bowel syndrome
Forshammar, J., Isaksson, S., Strid, H., Stotzer, P.-O., Sjövall, H., Simrén, M., & Öhman, L. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802272126 · Cited by 33
Schmulson, M., Bielsa, M. V., Carmona-Sánchez, R., Hernández, A., López-Colombo, A., López Vidal, Y., Peláez-Luna, M., Remes-Troche, J. M., Tamayo, J. L., & Valdovinos, M. A. (2014) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2014.01.004 · Cited by 29
Probiotic use in irritable bowel syndrome
Young, P., & Cash, B. D. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0053-1 · Cited by 22
Recent developments in the therapy of irritable bowel syndrome
Saad, R. J., & Chey, W. D. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.117 · Cited by 21
The Use of Probiotics in Functional Bowel Disease
Quigley, E. M. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.05.008 · Cited by 20
Probiotics in irritable bowel syndrome: an immunomodulatory strategy?
Quigley, E. M. M. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719648 · Cited by 19
Koh, S.-J., Lee, D. H., Lee, S. H., Park, Y. S., Hwang, J. H., Kim, J. W., Jeong, S. H., Kim, N., Im, J. P., Kim, J. S., et al. (2012) · The Korean Journal of Gastroenterology · doi:10.4166/kjg.2012.60.1.13 · Cited by 16
Metadata
- Authors
- Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R.
- Affiliations
- aDivision of Gastroenterology, University Hospital Nottingham, Nottingham, UK, bDepartment of Pathology, University Hospital Nottingham, Nottingham, UK, cDepartment of Public Health Medicine, University Hospital Nottingham, Nottingham, UK
- Nottingham University Hospitals NHS Trust (GB)
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2000-12-01
- Volume
- 47
- Issue
- 6
- Pages
- 804-811
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC1728147
- OpenAlex
- W1970178265
- Cited by
- 1,155
- References
- 51
- Citations by year
- 2026: 17 · 2025: 13 · 2024: 17 · 2023: 24 · 2022: 23 · 2021: 46 · 2020: 24 · 2019: 29 · 2018: 46 · 2017: 38 · 2016: 51 · 2015: 42 · 2014: 69 · 2013: 57 · 2012: 76
- FWCI
- 30.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gut (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- campylobacteriosis, enteroendocrine cells, T cells, intestinal permeability, intraepithelial lymphocytes, lamina propria lymphocytes, rectal mucosa, lactulose/mannitol ratio
- MeSH terms
- Acute Disease, Adult, Aged, Biopsy, Campylobacter Infections, Cell Count, Colonic Diseases, Functional, Enteritis, Female, Humans, Intestinal Mucosa, Life Change Events, Lymphocytosis, Male, Mast Cells, Middle Aged, Permeability, T-Lymphocytes, Antigens, CD, Enteroendocrine Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
